RHA 2, RHA 3, RHA 4 Dermal Fillers
FDA premarket approval P170002/S017 · decided 2021-05-26
Approval details
- PMA number
- P170002
- Supplement
- S017
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- RHA 2, RHA 3, RHA 4 Dermal Fillers
- Generic name
- Implant, dermal, for aesthetic use
- Applicant
- Teoxane S.A.
- Date received
- 2021-04-26
- Decision date
- 2021-05-26
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- LMH
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Geneva
- Statement
- Changing the precision of the analytical testing performed during receiving inspection of the needles of RHA2, RHA3 and RHA4 dermal fillers.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.